|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16724387.2 (espacenet) (Federated) (European Patent Register), 20160519 | | Patent/reg. no. and date | DK/EP 3298008, 20191120 | | Publication date | 20180328 | | Priority no. and date | WO PCT/EP2015/061153, 20150520 | | EP pub. no. and date |
EP 3298008 20180328 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P70828DK01 | | Inventor | LESCOP, Cyrille, c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 413/04 (2006.01) | | Title | KRYSTALLINSK FORM AF FORBINDELSEN (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPAN-1,2-DIOL | | Int. application no. | EP2016061200 | | Int. publication no. | WO2016184939 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
